Research in Progress | Rising Star Seminar

Title: The Digital Physiome: Wearables for progress Disease Detection and Monitoring

Abstract: Digital health is rapidly expanding due to surging healthcare costs, deteriorating health outcomes, and the growing prevalence and accessibility of mobile health and wearable technologies. Recent technological advancements make it possible to closely and continuously monitor individuals using multiple measurement modalities in real time. We are collecting and integrating such wearables data with clinical information to gain a more precise understanding of health and disease and develop actionable, predictive health models for improving outcomes. We are simultaneously developing open source data science and machine learning tools for the digital health community, including the Digital Biomarker Discovery Pipeline (DBDP), to facilitate the use of mobile device data in healthcare.

Jessilyn Dunn, PhD, is an Associate Professor of Biomedical Engineering and Biostatistics & Bioinformatics at Duke University. She directs the BIG IDEAs Lab, which is focused on digital health innovation, wearable sensors, and the development and validation of AI-driven digital biomarkers. Dr. Dunn is the Principal Investigator of research initiatives funded by the NIH, NSF, and FDA which are developing digital biomarkers of conditions ranging from pre- and type 2 diabetes to influenza-like illness to Opioid Use Disorder. Dr. Dunn was an NIH Big Data to Knowledge (BD2K) Postdoctoral Fellow at Stanford and an NSF Graduate Research Fellow at Georgia Tech and Emory, as well as a visiting scholar at the US Centers for Disease Control and Prevention and the National Cardiovascular Research Institute in Madrid, Spain. Her work has been internationally recognized with media coverage from the NIH Director’s Blog to Wired, Time, and US News and World Report. Dr. Dunn sits on the Google Consumer Health Advisory Panel and is a recipient of the NSF CAREER Award and the IEEE EMBS Early Career Achievement Award for her leadership and innovation across engineering and medicine.